Mark Rodgers

Search results

• 2022

  Somatrogon for treating growth disturbance in children and young people aged 3 and over: Cost comparison evaluation for the National Institute for Health and Care Excellence

  Rodgers, M., Murphy, P. J., Beresford, L., Harden, M., Simmonds, M. C. & Rothery, C., 2022, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report
• 2021

  Daratumumab in combination for newly diagnosed systemic amyloid light-chain amyloidosis: Evidence Review Group Report for the National Institute for Health and Care Excellence

  Faria, R., Rodgers, M., Saramago Goncalves, P. R., Anwer, S., Fulbright, H. A., Lachmann, H., Wechalekar, A., Dias, S. & Rothery, C., 2021, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report
• 2006

  The state of knowledge regarding tobacco harm, 1920-1964: industry and public health service perspectives.

  Forster, M., Walsh, M., Rodgers, M., Bowden, S. & Duffy, S., 2006, York: Centre for Historical Economics and Related Research at York. 56 p. (CHERRY Discussion Paper 1/06)

  Research output: Book/Report › Commissioned report
• 2005

  The effects of psychosocial interventions in cancer and heart disease: a review of systematic reviews

  Rodgers, M., Fayter, D., Richardson, G., Lewin, R., Sowden, A. J. & Ritchie, G., Dec 2005, York, UK: University of York. 178 p. (CRD Report)

  Research output: Book/Report › Commissioned report
• 2002

  Patient safety: a mapping of the research literature.

  Westwood, M., Rodgers, M. & Sowden, A., 2002, York: University of York.

  Research output: Book/Report › Commissioned report